Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minervini

Showing results (921-930 of 1,405) with videos related to

Pageof 141
Sort By:
Biomed Research International|May 19, 2015
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancerJlenia Brunetti, Chiara Falciani, Barbara Lelli, et al.
Research in Developmental Disabilities|April 17, 2012
Persons with Alzheimer's disease make phone calls independently using a computer-aided telephone systemViviana Perilli, Giulio E Lancioni, Nirbhay N Singh, et al.
The Journal of Urology|August 21, 2012
Zero ischemia laparoscopic radio frequency ablation assisted enucleation of renal cell carcinoma: experience with 42 patientsXiaozhi Zhao, Shiwei Zhang, Guangxiang Liu, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|February 16, 2023
Holmium laser enucleation of the prostate (HoLEP) is safe and effective in patients with high comorbidity burdenFabrizio Di Maida, Antonio Andrea Grosso, Riccardo Tellini, et al.
European Urology|April 21, 2020
Assessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Prioritisation Strategies During the COVID-19 Pandemic: Insights from Three Italian High-volume Referral CentresRiccardo Campi, Daniele Amparore, Umberto Capitanio, et al.
European Urology Oncology|November 9, 2023
Could a Risk-adapted Approach Support Shared Decision-making Regarding Eligibility for Adjuvant Pembrolizumab for Patients with Clear Cell Renal Cell Carcinoma at High Risk of Recurrence? A Multicentre Cohort StudyRiccardo Campi, Alessio Pecoraro, Eduard Roussel, et al.
Minerva Urology and Nephrology|July 13, 2026
Assessing the concordance between ChatGPT-4 and EAU guidelines indications in bladder cancer management: a real-world studyMattia Lo Re, Anna Cadenar, Marta Pezzoli, et al.
Biomarker Research|October 23, 2025
Splenomegaly in de novo acute myeloid leukemia is associated with ASXL1 mutations together with a distinct clinical and gene expression profileFrancesco Tarantini, Nicoletta Coccaro, Cosimo Cumbo, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|July 28, 2023
Predictors of early catheter replacement after HoLEP. Results from a high-volume laser centerFabrizio Di Maida, Anna Cadenar, Antonio Andrea Grosso, et al.
Trials|August 29, 2022
Preoperative smoking cessation program in patients undergoing intermediate to high-risk surgery: a randomized, single-blinded, controlled, superiority trialChristian D Fankhauser, Andres Affentranger, Beatrice Cortonesi, et al.
Pageof 141

Showing results (921-930 of 1,405) with videos related to

Sort By:
Pageof 141
Biomed Research International|May 19, 2015
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancerJlenia Brunetti, Chiara Falciani, Barbara Lelli, et al.
Research in Developmental Disabilities|April 17, 2012
Persons with Alzheimer's disease make phone calls independently using a computer-aided telephone systemViviana Perilli, Giulio E Lancioni, Nirbhay N Singh, et al.
The Journal of Urology|August 21, 2012
Zero ischemia laparoscopic radio frequency ablation assisted enucleation of renal cell carcinoma: experience with 42 patientsXiaozhi Zhao, Shiwei Zhang, Guangxiang Liu, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|February 16, 2023
Holmium laser enucleation of the prostate (HoLEP) is safe and effective in patients with high comorbidity burdenFabrizio Di Maida, Antonio Andrea Grosso, Riccardo Tellini, et al.
European Urology|April 21, 2020
Assessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Prioritisation Strategies During the COVID-19 Pandemic: Insights from Three Italian High-volume Referral CentresRiccardo Campi, Daniele Amparore, Umberto Capitanio, et al.
European Urology Oncology|November 9, 2023
Could a Risk-adapted Approach Support Shared Decision-making Regarding Eligibility for Adjuvant Pembrolizumab for Patients with Clear Cell Renal Cell Carcinoma at High Risk of Recurrence? A Multicentre Cohort StudyRiccardo Campi, Alessio Pecoraro, Eduard Roussel, et al.
Minerva Urology and Nephrology|July 13, 2026
Assessing the concordance between ChatGPT-4 and EAU guidelines indications in bladder cancer management: a real-world studyMattia Lo Re, Anna Cadenar, Marta Pezzoli, et al.
Biomarker Research|October 23, 2025
Splenomegaly in de novo acute myeloid leukemia is associated with ASXL1 mutations together with a distinct clinical and gene expression profileFrancesco Tarantini, Nicoletta Coccaro, Cosimo Cumbo, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|July 28, 2023
Predictors of early catheter replacement after HoLEP. Results from a high-volume laser centerFabrizio Di Maida, Anna Cadenar, Antonio Andrea Grosso, et al.
Trials|August 29, 2022
Preoperative smoking cessation program in patients undergoing intermediate to high-risk surgery: a randomized, single-blinded, controlled, superiority trialChristian D Fankhauser, Andres Affentranger, Beatrice Cortonesi, et al.
Pageof 141